bitBiome

Based in Japan, bitBiome, Inc. specializes in advanced genomic data analysis and enzyme development, focusing on harnessing the genomic information of Earth’s microorganisms for various applications. Founded in 2018 and headquartered in Tokyo, Japan, bitBiome, Inc. conducts research in genomic data analysis and enzyme development.

In May 2026, bitBiome, Inc. raised JPY 3. 5 billion in in seed funding from Darwin Ventures, In-Q-Tel and Valuence Ventures, with participation from IT-Farm Corporation. This round was part of a larger JPY 7 billion equity, grant and debt financing.

The CEO of the company is Yuji Suzuki, while the founder is Masahito Hosokawa. bitBiome specializes in genomic data analysis and enzyme development, offering a variety of sequencing services such as next-generation sequencing (NGS) and long-read sequencing. Their proprietary technologies, including the bit-MAP® single-cell genome analysis and the bit-GEM microbial genome database, enable enzyme discovery and engineering via the bit-QED platform. The company serves clients primarily in Japan and positions itself for global expansion, focusing on sectors like healthcare and biotechnology to foster decarbonization and a circular economy.

bitBiome generates revenue through a transaction model that focuses on B2B partnerships with research institutions and biotechnology companies. Their clients typically engage services through project-based agreements, allowing access to customized bioinformatics support and sequencing services, with pricing based on project complexity and scope. The company will use the May 2026 funding to expand its data platform, AI models, and global business development. The company plans to expand its product offerings and target new geographic markets, solidifying its position in the biomanufacturing and bioeconomy sectors.